Hippo (HIPO) Competitors $23.15 +0.89 (+4.00%) (As of 10:55 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends HIPO vs. CLOV, FIHL, SKWD, HG, LMND, ROOT, IGIC, BOW, TIPT, and AMBCShould you be buying Hippo stock or one of its competitors? The main competitors of Hippo include Clover Health Investments (CLOV), Fidelis Insurance (FIHL), Skyward Specialty Insurance Group (SKWD), Hamilton Insurance Group (HG), Lemonade (LMND), Root (ROOT), International General Insurance (IGIC), Bowhead Specialty (BOW), Tiptree (TIPT), and Ambac Financial Group (AMBC). These companies are all part of the "insurance" industry. Hippo vs. Clover Health Investments Fidelis Insurance Skyward Specialty Insurance Group Hamilton Insurance Group Lemonade Root International General Insurance Bowhead Specialty Tiptree Ambac Financial Group Clover Health Investments (NASDAQ:CLOV) and Hippo (NYSE:HIPO) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, media sentiment, community ranking, profitability, earnings and institutional ownership. Which has more risk & volatility, CLOV or HIPO? Clover Health Investments has a beta of 2.03, indicating that its share price is 103% more volatile than the S&P 500. Comparatively, Hippo has a beta of 1.26, indicating that its share price is 26% more volatile than the S&P 500. Do institutionals & insiders have more ownership in CLOV or HIPO? 19.8% of Clover Health Investments shares are owned by institutional investors. Comparatively, 43.0% of Hippo shares are owned by institutional investors. 22.3% of Clover Health Investments shares are owned by insiders. Comparatively, 11.4% of Hippo shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has preferable earnings & valuation, CLOV or HIPO? Clover Health Investments has higher revenue and earnings than Hippo. Clover Health Investments is trading at a lower price-to-earnings ratio than Hippo, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioClover Health Investments$2.03B1.06-$213.36M-$0.27-16.04Hippo$209.70M2.65-$273.10M-$7.11-3.13 Does the media favor CLOV or HIPO? In the previous week, Hippo had 26 more articles in the media than Clover Health Investments. MarketBeat recorded 29 mentions for Hippo and 3 mentions for Clover Health Investments. Hippo's average media sentiment score of 0.40 beat Clover Health Investments' score of 0.34 indicating that Hippo is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Clover Health Investments 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Hippo 6 Very Positive mention(s) 6 Positive mention(s) 16 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate CLOV or HIPO? Clover Health Investments currently has a consensus price target of $4.00, indicating a potential downside of 7.62%. Hippo has a consensus price target of $24.67, indicating a potential upside of 10.81%. Given Hippo's stronger consensus rating and higher possible upside, analysts clearly believe Hippo is more favorable than Clover Health Investments.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Clover Health Investments 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Hippo 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Is CLOV or HIPO more profitable? Clover Health Investments has a net margin of -7.30% compared to Hippo's net margin of -57.80%. Clover Health Investments' return on equity of -36.55% beat Hippo's return on equity.Company Net Margins Return on Equity Return on Assets Clover Health Investments-7.30% -36.55% -15.05% Hippo -57.80%-46.46%-11.11% Does the MarketBeat Community favor CLOV or HIPO? Clover Health Investments received 6 more outperform votes than Hippo when rated by MarketBeat users. Likewise, 38.89% of users gave Clover Health Investments an outperform vote while only 38.46% of users gave Hippo an outperform vote. CompanyUnderperformOutperformClover Health InvestmentsOutperform Votes2138.89% Underperform Votes3361.11% HippoOutperform Votes1538.46% Underperform Votes2461.54% SummaryClover Health Investments and Hippo tied by winning 9 of the 18 factors compared between the two stocks. Ad Porter & CompanyWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. Get Hippo News Delivered to You Automatically Sign up to receive the latest news and ratings for HIPO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HIPO vs. The Competition Export to ExcelMetricHippoFire, marine, & casualty insurance IndustryFinance SectorNYSE ExchangeMarket Cap$532.54M$43.40B$9.81B$19.28BDividend YieldN/A7.32%10.34%3.57%P/E Ratio-3.138.7344.8536.88Price / Sales2.651.903,415.1414.93Price / CashN/A18.1829.4420.54Price / Book1.402.093.995.42Net Income-$273.10M$3.90B$983.33M$987.01M7 Day Performance17.84%-0.28%-0.86%-0.32%1 Month Performance30.10%-0.96%-0.12%-0.67%1 Year Performance127.61%41.49%21.06%23.17% Hippo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HIPOHippo1.2218 of 5 stars$23.15+4.0%$24.67+6.6%+127.6%$576.90M$209.70M-3.26620Upcoming EarningsNews CoverageCLOVClover Health Investments1.1282 of 5 stars$4.33+3.1%$4.00-7.6%+297.2%$2.09B$2.03B-16.04552Upcoming EarningsFIHLFidelis Insurance3.745 of 5 stars$16.98-0.2%$20.44+20.4%+19.8%$2.01B$3.60B4.4577Upcoming EarningsSKWDSkyward Specialty Insurance Group4.1553 of 5 stars$43.31-0.9%$45.22+4.4%+55.1%$1.75B$885.97M13.20400Earnings ReportHGHamilton Insurance Group3.1705 of 5 stars$17.55+3.0%$21.43+22.1%N/A$1.74B$1.57B4.24550Upcoming EarningsLMNDLemonade2.4964 of 5 stars$23.57-2.4%$21.33-9.5%+36.1%$1.72B$429.80M-7.751,258Earnings ReportROOTRoot2.3703 of 5 stars$70.96-0.1%$57.38-19.1%+613.9%$1.07B$455M-57.69760Earnings ReportAnalyst ForecastInsider SellingIGICInternational General Insurance2.6119 of 5 stars$21.38-1.6%$19.00-11.1%+92.3%$998.12M$472M8.38290BOWBowhead Specialty1.7851 of 5 stars$29.68+1.0%$30.00+1.1%N/A$969.35MN/A0.00193Gap DownTIPTTiptree1.3233 of 5 stars$20.44+1.2%N/A+16.9%$751.99M$1.99B21.071,132Dividend AnnouncementAMBCAmbac Financial Group4.0209 of 5 stars$11.21flat$17.00+51.7%-10.3%$531.80M$269M7.09130Upcoming Earnings Related Companies and Tools Related Companies Clover Health Investments Alternatives Fidelis Insurance Alternatives Skyward Specialty Insurance Group Alternatives Hamilton Insurance Group Alternatives Lemonade Alternatives Root Alternatives International General Insurance Alternatives Bowhead Specialty Alternatives Tiptree Alternatives Ambac Financial Group Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:HIPO) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hippo Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hippo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
